Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer

The aim of this study was to compare the effectiveness and toxicity of neoadjuvant chemotherapy regimens, xeloda/epirubicin/cyclophosphamide (XEC) vs 5-fluorouracil/epirubicin/cyclophosphamide (FEC), followed by adjuvant chemotherapy regimens, capecitabine/taxotere (XT) vs taxotere (T), in axillary...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Minmin, Wei, Wei, Liu, Jianlun, Yang, Huawei, Jiang, Yi, Tang, Wei, Li, Qiuyun, Liao, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907713/
https://www.ncbi.nlm.nih.gov/pubmed/27354816
http://dx.doi.org/10.2147/OTT.S104431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907713/
https://www.ncbi.nlm.nih.gov/pubmed/27354816
http://dx.doi.org/10.2147/OTT.S104431

Ejemplares similares